Haematin (haem) polymerization and its inhibition by quinoline antimalarials
- 1 July 1997
- journal article
- research article
- Published by Taylor & Francis in Pathogens and Global Health
- Vol. 91 (5) , 559-566
- https://doi.org/10.1080/00034983.1997.11813174
Abstract
Haematin (ferriprotoporphyrin IX) is released from haemoglobin during its degradation in the malarial parasite's food vacuole and is detoxified by its polymerization into a form of β-haematin called haemozoin, or malarial pigment. This process is protein independent in vitro. Quinoline antimalarial blood schizonticides accumulate in the food vacuole and may inhibit haematin polymerization by binding to haematin and preventing its incorporation into the growing haemozoin chain. Drug resistance to quinolines is thought to be due to reduced accumulation of the drug in the food vacuole. As some quinolines can overcome this resistance, quinolines, as a class, remain a potential source of future antimalarial drugs.Keywords
This publication has 40 references indexed in Scilit:
- The Plasmodium digestive Vacuole: Metabolic Headquarters and Choice Drug TargetParasitology Today, 1995
- Quinoline anti‐malarial drugs inhibit spontaneous formation of β‐haematin (malaria pigment)FEBS Letters, 1994
- MefloquineDrugs, 1993
- Pyronaridine: A new antimalarial drugParasitology Today, 1991
- Chloroquine poisoning in a childAnnals of Emergency Medicine, 1990
- Point mutations and pyrimethamine resistance in Plasmodium falciparumParasitology Today, 1989
- A ferriprotoporphyrin IX‐chloroquine complex promotes membrane phospholipid peroxidation A possible mechanism for antimalarial actionFEBS Letters, 1987
- A nuclear magnetic resonance study of the interactions of antimalarial drugs with porphyrinsBiochimica et Biophysica Acta (BBA) - General Subjects, 1985
- The Malaria Parasite Monitored by Photoacoustic SpectroscopyScience, 1984
- Lethality and Behavioral Side Effects of ChloroquineJournal of Clinical Psychopharmacology, 1982